Transl Neurodegener. 2025 Feb 7;14(1):7. doi: 10.1186/s40035-025-00469-6.
PMID:39920796
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Street D, Jabbari E, Costantini A, Jones PS, Holland N, Rittman T, Jensen MT, Chelban V, Goh YY, Guo T, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Houlden H, Morris H, Rowe JB.
Brain. 2023 Aug 1;146(8):3232-3242. doi: 10.1093/brain/awad105.
PMID:36975168
Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis.
Fan CC, Han C, Wang XM, Chhetri JK, Mao W, Xu EH, Liu SY, Chan P.
Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group.
Pellecchia MT, Stankovic I, Fanciulli A, Krismer F, Meissner WG, Palma JA, Panicker JN, Seppi K, Wenning GK; Members of the Movement Disorder Society Multiple System Atrophy Study Group.